ARCHIVES

FDA Approves Novartis Drug Zometa For Multiple Myeloma And Bone Mets.

This article is from The Cancer Letter archive.

Vol. 28 No. 09 | March 1, 2002

Download PDF Visit The Full Archive

Related Articles

Concepts Approved For New Technology In Computers, Recompetition

November 6, 1987

In Brief: ACR Moving To D.C.; FDA Advisors OK VP-16 NDA; Wiernik Tells Missouri No; Dewys Moves To DRCCA

October 15, 1982

In Brief: Senate Subcommittee Recommends $1 .52 Billion

September 25, 1987

Reinventing NCI: Clinical Trials System Changes Not Easy Or Quick, Klausner Says; NCAB Members, Others, Sound Off On Group’s Report

October 10, 1997

NCAB Votes To ‘Keep Alive’ Concept For Stage 2 Breast Cancer Fat Trial

February 14, 1986

B-27 Finds Improved CR For Taxotere Prior To Surgery

November 28, 2003